Full text is available at the source.
β2‐agonist treatment enhances uterine oxytocin receptor mRNA expression in pregnant rats
Beta 2-agonist treatment increases uterine oxytocin receptor gene activity in pregnant rats
AI simplified
Abstract
Fenoterol administration led to a maximum 125% increase in oxytocin receptor mRNA expression in the late-pregnant rat uterus.
- Hexoprenaline induced a maximum 24% increase of oxytocin receptor mRNA.
- Fenoterol treatment resulted in a fourfold increase in oxytocin receptor mRNA in vitro.
- The contractility effect of oxytocin on uterine rings was significantly enhanced in fenoterol-treated rats compared to intact term pregnant rats.
- The EC50 values for oxytocin's effect on uterine contractility were not statistically different between the groups.
- The increase in oxytocin receptor mRNA expression induced by Beta(2)-agonists may hinder the effectiveness of these drugs in treating preterm uterine contractions.
AI simplified